Biomarker-free dielectrophoretic sorting of differentiating myoblast multipotent progenitor cells and their membrane analysis by Raman spectroscopy. by Muratore, Massimo et al.
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Biomarker-free dielectrophoretic sorting of differentiating
myoblast multipotent progenitor cells and their membrane
analysis by Raman spectroscopy.
Citation for published version:
Muratore, M, Srsen, V, Waterfall, M, Downes, A & Pethig, R 2012, 'Biomarker-free dielectrophoretic sorting
of differentiating myoblast multipotent progenitor cells and their membrane analysis by Raman
spectroscopy.' Biomicrofluidics, vol. 6, no. 3, 034113. DOI: 10.1063/1.4746252
Digital Object Identifier (DOI):
10.1063/1.4746252
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Peer reviewed version
Published In:
Biomicrofluidics
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 05. Apr. 2019
Biomicrofluidics 6, 034113 (2012) 
 1 
Biomarker-free dielectrophoretic sorting of differentiating myoblast 
multipotent progenitor cells and their membrane analysis by Raman 
spectroscopy 
 
Massimo Muratore1, Vlastimil Srsen2, Martin Waterfall3, Andrew Downes4, Ronald 
Pethig1*. 
1
 Institute for Integrated Micro and Nano Systems, 4 Institute for Materials and Processes, School of 
Engineering, The University of Edinburgh, Edinburgh EH9 3JF, UK 
2 Wellcome Trust Centre for Cell Biology, The University of Edinburgh, Edinburgh EH9 3JR, UK 
3  Institute of Immunology & Infection Research, School of Biological Sciences, The University of 
Edinburgh, Edinburgh EH9 3JR, UK 
 
Myoblasts are muscle derived mesenchymal stem cell progenitors that have great 
potential for use in regenerative medicine, especially for cardiomyogenesis grafts and 
intracardiac cell transplantation.  To utilise such cells for pre-clinical and clinical 
applications, and especially for personalized medicine, it is essential to generate a 
synchronised, homogenous, population of cells that display phenotypic and genotypic 
homogeneity within a population of cells.  We demonstrate that the biomarker-free 
technique of dielectrophoresis (DEP) can be used to discriminate cells between stages 
of differentiation in the C2C12 myoblast multipotent mouse model.  Terminally 
differentiated myotubes were separated from C2C12 myoblasts to better than 96% 
purity, a result validated by flow cytometry and Western blotting.  To determine the 
extent to which cell membrane capacitance, rather than cell size, determined the DEP 
response of a cell, C2C12 myoblasts were co-cultured with GFP-expressing MRC-5 
fibroblasts of comparable size distributions (mean diameter ~10 µm).  A DEP sorting 
efficiency greater than 98% was achieved for these two cell types, a result concluded 
to arise from the fibroblasts possessing a larger membrane capacitance than the 
myoblasts.  It is currently assumed that differences in membrane capacitance 
primarily reflect differences in the extent of folding or surface features of the 
membrane.  However, our finding by Raman spectroscopy that the fibroblast 
membranes contained a smaller proportion of saturated lipids than those of the 
myoblasts suggests that the membrane chemistry should also be taken into account.   
                                                 
*
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I. INTRODUCTION 
Myoblasts, a mesenchymal stem cell derived precursor, have the ability to 
differentiate into diverse cell lineages by means of chemical cues and/or co-factors 
present in the culture media1,2.  These multipotent characteristics and the availability 
of these cells make them amenable for regenerative medicine applications.  Several 
studies have reported the use of these cells for cardiomyogenesis grafts3, intracardiac 
cell transplantation4,5 and also early pre-clinical studies have shown successful 
implantation in human patients with ischemic heart failure6,7.  Although the initial 
reports appear promising there is scant information about the optimal differentiation 
status5,8 and how to distinguish the phenotypical and physiological variations in a 
population of cells for implantation.  The work reported here demonstrates that these 
issues may possibly be addressed using dielectrophoresis (DEP).   
 
Traditional methods such as flow cytometry identify and characterise specific cell 
attributes by utilising labelled antibodies to specific biological markers that may 
change the physiology of the cells selected, rendering further medical applications 
challenging.  DEP, as recently reviewed9-12 is a biomarker-free technique that utilises 
the induced dynamic response of a cell to imposition of a non-uniform radio-
frequency electric field.  For a particular field frequency, the DEP response of a cell 
depends on whether its intrinsic dielectric polarisability is less or greater than that of 
its surrounding suspending medium.  For the range of field frequencies and 
experimental conditions used in this study, the observed dynamic response is 
characterised either by the cell moving up a field gradient towards an electrode 
(positive DEP) or down a field gradient away from an electrode (negative DEP).  The 
transition between these types of DEP response corresponds to where the effective 
polarisability of the cell equals that of the surrounding medium and occurs at the so-
called DEP cross-over frequency fxo.  For a spherical cell of radius r this frequency is 
given to good approximation by:   
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In this equation Cm is the specific capacitance (capacitance per unit area) of the cell 
membrane, σm is the conductivity of the suspending medium, and the assumption is 
made that the high resistance to passive ion flow across the membrane has not been 
impaired due to the onset of cell death or physical damage, for example13.  The 
protocols for obtaining the cell separations reported here relied on the different cell 
types (C2C12 myoblasts, myotubes and MRC-5 fibroblasts) exhibiting different fxo 
values.  This can reflect differences in either or both their average cell size or 
membrane capacitance.  A cell’s plasma membrane acts as a capacitor because it is 
constructed like one - namely a thin dielectric shell situated between two conductors 
(the outer and inner electrolytes).  It is customary to employ the low-frequency (DC) 
approximation14 to analyse the dielectric and conductive properties of a cell, so that 
for a spherical cell of measured radius r the effective permittivity εeff of a cell is given 
by: 
 
 mm
mo
eff Cr
r
== φδ
εε
ε  (2) 
 
where δ is the membrane thickness, εo the permittivity of free space, and εm is the 
mean relative permittivity of the material forming the membrane structure.  The factor 
φm in equation (2) is termed the membrane-folding factor to take into account cell 
surface features such as folds, microvilli, ruffles and blebs15. For a perfectly smooth 
spherical cell φm = 1.  The DEP measurements reported here did not extend above 700 
kHz, a suspending medium conductivity of 120 mS/m was used, and high cell 
viabilities were maintained during their DEP separations.  Under these conditions the 
low-frequency approximation used in equation (2) leads to an accurate measurement 
of the membrane capacitance16.  Labeed et al17 have recently reported that the 
neurogenic potential of human neural stem/progenitor cell populations can be 
discriminated by their fxo and derived Cm values.  On the basis of the efficient DEP-
based cell separations reported here, the same conclusion may be reached regarding 
discrimination between stages of C2C12 myoblast cell differentiation.   
 
In the DEP literature9, 13, 15 it has been assumed that the value of Cm primarily depends 
on the extent of membrane folding as given by φm.  One of the objectives of this work 
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was to investigate to what extent the chemical composition of the membrane might 
also influence its specific capacitance value.  Raman spectroscopy has previously 
been used to investigate chemical changes associated with the differentiation of stem 
cells18-20, as well as an on-chip detection method for monitoring the DEP separation of 
bacteria21.  In this work we have used Raman spectroscopy to determine how 
differences in the molecular composition of the membranes of two cell types of 
similar size, namely C2C12 myoblasts and MRC-5 fibroblasts, might correlate with 
their observed DEP responses and derived Cm values.   
 
II. MATERIALS AND METHODS 
All the chemical and reagents were purchased from Sigma (Poole, UK) unless 
otherwise stated.  
A. Cell cultures 
i) C2C12 mouse myoblast cell line:  
Cells were plated at a density of 3000 cells/cm² and grown in high glucose DMEM 
growth medium (GM) supplemented with 10% FBS (HyClone), 2 mM of L-
glutamine, 100 units/ml of penicillin and 100 µg/ml streptomycin sulphate 
(Invitrogen).  Cells were passaged every two days at a ratio of 1:9 and they were 
induced to myogenic differentiation at 90% confluence.  The differentiation medium 
(DM) was composed of high glucose DMEM, 0.1% FBS (Hyclone), 100 units/ml of 
penicillin and 100 µg/ml streptomycin sulphate (Invitrogen), 5 µg/ml transferrin and 
10 µg/ml insulin.  The DM was changed every other day.  All cultures were kept at 
37ºC with 5% CO2.  C2C12 myoblasts differentiate and fuse into phenotypically 
distinct elongated multinuclear myotubes that express embryonic myosin22, 23. 
 
Images are given in Figure 1 of a C2C12 culture at the time (day 1) of seeding; at the 
first stage of myotube formation 2 days after induction (on day 2 after seeding); at the 
stage (day 7 after induction) where the cells were prepared for DEP separation. 
 
ii) MRC-5-GFP fibroblasts:  
The cells were cultured in the same GM as C2C12, and were further supplemented 
with 2 µl/ml puromycin to maintain selection pressure, as well as green fluorescent 
protein (GFP) expression.  The cells were passaged every two days at a ratio of 1:4. 
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iii) Co-culturing:  
To characterise the DEP properties of cells of a similar size (~ 10 µm diameter), 
MRC-5-GFP fibroblasts were used as a feeder layer for co-culturing C2C12 
myoblasts.  The medium for both cell types was GM supplemented with 2 µg/ml of 
puromycin (to select for GFP expression) and cultured for a week before analysis.  
Because of the GFP expression the MRC-5-GFP fibroblasts and C2C12 myoblasts 
could readily be identified by flow cytometry. 
 
B. Flow Cytometry  
Samples were analysed using a LSRII flow cytometer (Beckton Dickinson 
Immunocytometry Systems, UK) running BD FACSDiva v6 Software.  An electronic 
acquisition gate was applied to the forward/side scatter (FSC/SSC) plot to exclude 
debris from intact material and typically more than 50,000 events were acquired in 
this gate.  GFP or Alexa Fluor 488 conjugated secondary antibody binding was 
detected using 488 nm laser excitation and a recording of fluorescence in the range 
500-550 nm.  Analysis was performed using FlowJo software (Tree Star, USA).  
Debris was excluded through FSC/SSC profile gating before applying electronic gates 
to assess green fluorescence.  Sort purity was calculated through gating based on 
profiles from each cell type as controls.   
 
For analysis of myotubes, cells were collected separately from the central and outer 
exit ports of the DEP chamber and washed in PBS (Mg++-, Ca++-free) supplemented 
with 0.1% BSA fraction V and 0.1% NaN3.  The cells were centrifuged at 350 g for 5 
minutes and the pellet was re-suspended and fixed in 2% formaldehyde solution for 
10 minutes at room temperature.  The fixed cells were washed in permeabilisation 
buffer (PB) composed of PBS (Mg++-, Ca++-free) supplemented with 0.1% BSA V, 
0.1% NaN3 azide and 0.1% saponin (S-7900).  Primary antibodies for embryonic 
myosin (specific for myotubes) were diluted in 100 µl of PB for incubation with the 
cell samples for 90 minutes at 40C.  After primary antibody incubation cells were 
centrifuged and washed in a single large volume (3ml) of PB.  Secondary antibodies, 
conjugated with Alexa Fluor 488, were added to cells suspended in PB and 
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incubated for another 90 min at 40C.  Finally, the cells were re-suspended in 400 µl of 
F-PBS and flow cytometry analysis performed. 
 
For C2C12 myoblasts co-cultured with MRC-5-GFP fibroblasts, the separation 
performance by DEP was assessed by flow cytometry.  The cells were collected 
separately from the two exit ports of the DEP chamber and washed in Flow-PBS (F-
PBS) composed of PBS (Mg2+, Ca2+ free) supplemented with 0.1% NaN3 and 0.2% 
BSA V prior to acquisition.  
 
Propidium iodide (PI), which is membrane impearmeable and excluded from viable 
cells, was used as a fluorescent DNA stain to evaluate cell viability after DEP 
separation.  Immediately prior to cell acquisition for viability, 10µl PI solution 
(50µg/ml PI + 100µg/ml RNase in PBS) was added directly to sample tubes and 
staining detected using 488 nm laser excitation and recording of fluorescence in the 
range 633-677 nm . Viability was calculated through gating based on profiles from 
unstained samples. 
 
C. DEP studies 
Details of the design and basic operation of the DEP chamber used for the cell 
separations are shown in Figures 2 and 3.  The ‘fishbone’ quadrupole geometry of the 
electrodes is a modified version of designs incorporated into DEP cell manipulation 
and separation devices described by other laboratories21,24-28.  Following the 
procedure described by Hu et al26 the cell mixture (~4x106 cells/ml) entered the 
chamber through two ports at the sides of the chamber.  The widths of these two flow 
streams were ~440 µm.  Buffer fluid of the same conductivity as that used to suspend 
the cell mixture was introduced into the chamber through a centre port, to produce a 
cell-free central stream of width ~120 µm.  The selective separation of target cells 
from a mixture was achieved by steadily deflecting them by negative DEP from the 
outer laminar flow streams into the central fluid stream.  As depicted in Figure 3 other 
cells remained in the two outer fluid streams, either because they did not experience a 
sufficiently strong negative DEP force to overcome the hydrodynamic force, or a 
positive DEP force attracted them towards the electrodes.  The electrodes (~0.2 µm) 
were sufficiently thin compared with the fluid channel height (100 µm) that their 
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influence on the laminar flow profile in the chamber was negligible.  Tests were also 
made to confirm that, with no voltage signal applied to the electrodes, cells injected 
into the two side ports were carried through the chamber with no observable diffusion 
into the central fluid stream.  The final design of the chamber resulted from tests and 
successive modifications of various prototypes, some of which are described in 
section III.B.   
 
Platinum (200 nm thick) electrodes were sputtered onto a seed layer of titanium (20 
nm) on glass substrates using standard photolithography and lift-off techniques.  The 
electrodes, each of width 15 µm and spaced 500 µm apart, were grouped into three 
equally spaced sets of five quadrupole ‘funnel’ arrays angled at 18o to the direction of 
intended fluid flow (see Figure 3).  The gap between the tips of adjacent (coplanar) 
electrodes was 100 µm for the first set of five quadrupoles to be located next to the 
fluid inlet ports, and this was reduced to 75 and then 50 µm for the next two sets.  The 
fluidic chamber, length 9.4 mm, height 100 µm and width 1 mm, was fabricated by 
patterned photolithography with SU-8.  The two glass substrates were bonded to face 
each other onto the SU-8 fluidic framework, using alignment marks to ensure close (± 
2 µm) matching of the upper and lower sets of electrodes.  By this means a total of 15 
quadrupole ‘funnel’ electrode arrays were established along the length of the DEP 
chamber.  The chamber was mounted onto a custom made holder for fluidic and 
electrical connections (Figure 2), and two syringe pumps (Harvard Apparatus) were 
used for the separate pumping of the DEP fluid medium (without cells) and cell 
suspensions into the chamber.  Cells were collected at room temperature (~294K) 
from the two outlet ports for further analysis.  Prior to use, the DEP chamber was 
filled with 20% BSA for 10 min and then flushed through with 70% ethanol - a 
procedure adopted to reduce cell adhesion to the chamber walls and the formation of 
air bubbles, respectively.  For the DEP cell separations reported here a volumetric 
flow rate of 120 µl/h was established for periods of 2~3 hours, so as to collect at least 
~5x105 cells from the exit fluidic ports for flow cytometry analysis.  The conductivity 
of the DEP medium was adjusted to ~120 mS/m with osmolarity calculated at ~330 
mOsm/kg.  Sinusoidal voltages of 10 V(pk-pk) were applied to the electrodes over the 
frequency range 150 - 700 kHz using an Agilent/HP 3325A function generator.   
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D. Western Blotting:  
Myoblasts and myotubes were mixed prior to sorting by the DEP device and the 
separated fractions were collected for Western blot analysis.  Cells were centrifuged 
at 250 g and re-suspended in cold PBS.  The suspension was centrifuged at 350 g for 
three minutes and the pellet was re-suspended in three parts of distilled water and one 
part of 4x NuPAGE-SDS Sample Buffer (Invitrogen) supplemented with 10% of β-
Mercaptoethanol.  The samples were denatured by boiling for six minutes.  Proteins 
were resolved by 6% SDS-PAGE and transferred to a nitrocellulose membrane (LI-
COR Bioscience).  The membrane was blocked in 5% milk in TBS containing 0.1% 
Tween 20 over night.  The blocking procedure was followed by one hour incubation 
with antibodies against embryonic myosin (EMHC, clone F1.652, developed by 
Helen Blau, University of Iowa) diluted 1:1000 and anti-α tubulin antibody diluted 
1:5000 (clone B-5-1-2 Sigma).  The primary antibody was detected with secondary 
IR800 conjugated goat anti-mouse antibody (LI-COR Bioscience) at room 
temperature for 2 hours.  Visualisation of the signal was performed using a LI-COR 
Odyssey near-infrared scanner and Odyssey 3.0,16 software with median background 
subtraction. 
 
E. Plasma membrane purification 
Plasma membranes from C2C12 myoblasts, myotubes and MRC-5-GFP fibroblasts 
were purified by a two-phase partition process29 except that cell disruption was 
achieved by homogenisation with a dounce and pestle pre-chilled at -200C.  The 
plasma membrane preparations from all three cell types were collected and dried 
under a stream of nitrogen before Raman spectroscopy. 
 
F. Raman spectroscopy 
Raman spectra were obtained using a Renishaw inVia Raman microscope (785 nm 
near-IR laser excitation, 40 mW at sample) with a 40x objective lens and 0.75 
numerical aperture.  The membranes were deposited onto a quartz substrate (SPI 
Supplies), dried under a stream of nitrogen and positioned on the inverted stage of the 
microscope.  Each spectrum was acquired over approximately 2 minutes for six 
samples obtained from the membranes of the C2C12 myoblasts, myotubes and MRC-
5-GFP fibroblasts.  Principal component analyses (PCA) were performed for six 
separate spectra obtained from the membranes of each of the three cell types (C2C12 
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myoblasts, myotubes and MRC-5-GFP fibroblasts).  PCA is an analytical procedure30 
that aids the identification of the principle differences between samples by translating 
a high number of possibly correlated variables into a smaller number of uncorrelated 
principal components.  This exercise was undertaken to determine how differences in 
the molecular composition of the membranes of the different cell types might 
correlate with their observed DEP responses and derived Cm values.   
 
III. RESULTS 
A. Flow Cytometry  
Immediately after harvesting the cells were transferred into DEP medium, pumped 
into the DEP chamber and the cell populations eluted from the central and side flow 
streams were collected for analyses by flow cytometry.  Purity of the recovered sub-
populations was assessed based on either the intrinsic GFP expression of the MRC-5 
fibroblasts or staining for myotubes with anti-embryonic myosin antibody, detected 
using a secondary Alexa Fluor 488 antibody.  Analyses of cell mixtures that had 
been pumped through the DEP chamber with no voltages applied to the electrodes are 
shown in Figure 4(a), and were used to determine the appropriate gating strategy for 
flow cytometry evaluation of DEP separated sub-populations.  The DEP separation 
and analysis by flow cytometry was performed for 13 separate samples of each paired 
combination of the three cell types, with the results expressed as percentages of cells 
that were determined by flow cytometry to be positive for GFP or Alexa Fluor 488, or 
fluorescence negative.   
 
The forward scatter plots obtained for C2C12 myoblasts (n = 59,518) and MRC-5-
GFP fibroblasts (n = 23,343) are shown superimposed in Figure 4(b).  Under 
microscopic inspection (x200) these two cell types appeared to be of closely similar 
size (~10 µm diameter) and size distribution, and this conclusion is supported by the 
forward scatter data.  The results shown in Figure 4(b) give median FSC-A values of 
98.05 K and 86.72 K for the C2C12 and MRC-5 cells respectively, with median 
absolute deviations of 47.1% and 55.7%, respectively (the median, rather than mean, 
is generally used in flow cyotmetry as data rarely has a symmetrical unimodal 
distribution).  These results indicate that, although there was a relatively small 
difference in their average size, the C2C12 and MRC-5 cells exhibited almost 
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completely overlapping size distributions.  The observed large biological varience in 
morphological size is not unusual.  Based on this FSC data and the estimated average 
cell size of 10 µm diameter for their mixtures, the C2C12 cells were estimated on 
average as 13% larger in diameter and of a more narrow size distribution than the 
MRC-5 cells.   
 
B. DEP cell separations 
Initial considerations of the design and testing of the DEP device included an 
estimation of the optimal rate of fluid flow through the chamber.  The electrodes 
direct a cell into the central flow stream when the negative DEP force acting on it 
exceeds the Stokes hydrodynamic drag force.  Adopting the effective dipole moment 
approximation9 for the time-averaged DEP force acting on a spherical particle of 
radius r, this condition can be expressed as  
 
 θηpiεεpi sin6)Re(2 23 rvECMrflo >∇  (4) 
 
where εfl is the relative permittivity (~79) of the aqueous suspending fluid, Re(CM) is 
the real part of the Clausius-Mossottti factor that quantifies the effective polarizability 
of the particle, E is the rms value of the applied electric field, η is the dynamic 
viscosity of the fluid, v is the fluid velocity, and θ is the angle (18o) at which the 
electrodes were set against the direction of fluid flow.  The CM factor is bounded by 
the limits -0.5 < Re(CM) < 1.0, and as a first approximation it was assumed that an 
Re(CM) vaue of -0.2 is sufficient to achieve the required negative DEP force for a cell 
to be deflected from the outer flow streams towards the central one.  From equation 
(4), for a cell of radius 5 µm in an aqueous fluid (η = 10-3 Pa.s) and electrodes angled 
at θ = 18o, the minimum value of ∇E2 required to direct cells into the central fluid 
stream is:   
 
 vE 192 101.2 ×>∇    (V2/m-3)  (5) 
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Approximating the fluidic chamber as two smooth infinite parallel plates, and 
assuming the flow to be laminar, the fluid velocity v(x) as a function of height x above 
the chamber floor is given by31:  
 
 
[ ]2)/()/(6)( hxhxvxv −=  (6) 
 
where v  is the mean flow velocity.  For a channel height h = 100 µm, v(x) = v  at x = 
14.6 µm.  Values for the field gradient and ∇E2 generated by a single quadrupole 
electrode structure were determined using COMSOL Multiphysics (version 3.5) 
software, and this indicated that values for ∇E2 of the order 5x1015 V2/m3 are created 
at a distance of 14.6 µm above the electrode edges with an applied voltage of 10 
V(pk-pk).  From equation (5) this provided, for the case of a single quadrupole array 
and an applied voltage of 10 V(pk-pk), the guideline of ~2.4 x 10-4 m/s as the 
maximum fluid velocity to be used to achieve deflection of cells passing to within ~15 
µm of an electrode edge.  For the DEP chamber cross-section of 100 µm x 1 mm, this 
corresponded to a maximum volumetric flow rate of ~86 µl/hr for the case of one 
electrode array.  After testing several prototypes, the strategy adopted to achieve 
maximum cell separation purity was to employ a volumetric flow rate of 120 µl/hr 
with 15 quadrupole electrode arrays in the chamber (compared to the three electrode 
arrays used by Hu et al26).   
 
C2C12 myoblasts were passaged and differentiated into myotubes as described in 
section II.A.  From 40% to 70% of C2C12 myoblasts differentiated into myotubes, 
depending on passage number of the cells.  To determine the voltage frequency for 
the most efficient cell separation, cell samples were pumped through the DEP 
chamber for a range of frequencies, commencing at 150 kHz, and samples collected 
from the exit ports were analysed by flow cytometry.  Results obtained for a sample 
containing C2C12 myoblasts, 9 days after plating and 7 days after induction to 
produce myotubes, are shown in Figure 5.  DEP separation performed at 150 kHz 
resulted in elution of a mixture of C2C12 myoblasts and myotubes from the central 
flow stream.  However, as shown in Figure 5(a), with increasing voltage frequency 
the ratio of C2C12 myoblasts to myotubes collected from the central port increased, 
until at 400 kHz about 95% of the cells collected from the central port were C2C12 
Biomicrofluidics 6, 034113 (2012) 
 12 
myoblasts.  This result indicates that for frequencies in the range 350-400 kHz the 
myotubes were either close to their average DEP cross-over (fxo) frequency or 
experienced a weak positive DEP force.  As shown in Figure 4(b) 98.6% of the cells 
collected from the outer flow streams at 409 kHz were myotubes (positive to the 
Alexa Fluor 488 probe) and, as indicated in Figure 4(c), the C2C12 viability was 
typically around 96% after DEP separation.  Variable, better than 65%, viability was 
determined for the DEP separated myotubes.  The undifferentiated C2C12 myoblasts 
can be expected to be far less sensitive to environmental change than the contractile 
differentiated myotubes.  A highly efficient separation of the C2C12 myoblasts from 
the differentiated myotubes with limited viability loss had therefore been achieved at 
409 kHz.  Above 409 kHz the number of C2C12 cells collected from the central port 
decreased, until at 670 kHz very few cells appeared in the central flow stream.  This 
frequency can be considered to be close to fxo for the C2C12 myoblasts.    
 
As an additional validation of the efficient separation by DEP of C2C12 myoblasts 
from myotubes, a Western blot analysis for the marker embryonic myosin was 
performed.  This protein is only present in the late phase of development from C2C12 
myoblasts to differentiated myotubes22, 23.  The cells were mixed and sorted by DEP at 
400 kHz, and samples collected from the centre and outer flow ports were analysed as 
described in section II.D for embryonic myosin.  Tubulin-α was used as loading 
control to calibrate for protein content.  The results given in Figure 6 show that the 
only cells positive for embryonic myosin were those collected from the outer flow 
port, and that none of this protein was detected in the sample obtained from the centre 
port of the DEP chamber.  This finding is compatible with the results shown in Figure 
5.  Although this is a less quantitative method than flow cytometry, it provided further 
validation of the high level of cell separation achieved using the DEP chamber design 
and protocol described here.   
 
A 409 kHz separation of C2C12 myoblasts from myotubes was used to produce pure 
populations of these cells for tests of the DEP separation of C2C12 co-cultured with 
MRC-5-GFP cells, and of myotubes mixed with MRC-5-GFP cells.  Where possible, 
depending on their concentrations after DEP sorting, roughly equal numbers of cells 
were used to prepare heterogeneous samples of myotubes with the MRC-5-GFP cells.  
Biomicrofluidics 6, 034113 (2012) 
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Mixing of the C2C12 myoblasts and MRC-5-GFP fibroblasts before DEP separation 
was not required as the MRC-5 feeder cells were co-cultured with C2C12 cells.  The 
flow cytometry control experiments for setting the appropriate gating for these 
samples are shown in Figure 4.  The results leading to the best DEP separation of 
C2C12 co-cultured with MRC-5-GFP are given in Figure 7, and indicate that fxo for 
the MRC-5-GFP fibroblasts was close to 500 kHz.  At this frequency 99.9% of the 
cells collected from the centre port were C2C12 myoblasts, and the MRC-5-GFP cells 
accounted for 97.7% of the cells collected from the outer port.  Based on flow 
cytometry data after PI cell staining, cell viabilities were typically found to be above 
97%.  The results associated with the most efficient separation of a mixture of 
myotubes and MRC-5-GFP fibroblasts are shown in Figure 8.  From these results it 
can be deduced that fxo for myotubes was close to 400 kHz, at which frequency 100% 
of the cells collected from the centre port were determined to be MRC-5-GFP 
fibroblasts, whilst 99.1% of the cells eluted from the outer port were myotubes.   
 
C. Raman spectroscopy  
The spectra obtained for membrane samples extracted from the C2C12 myoblasts and 
MRC-5-GFP fibroblasts are shown in Figure 9.  The most significant differences in 
membrane chemistry are indicated by the vibrational frequency ranges 1 and 2, 
corresponding to CH2 and CH3 bending (1300 - 1500 cm-1)32-34 and stretching for 
saturated long CH chains (2800 - 2950 cm-1)35-37.  A principle component analysis of 
the Raman spectra shown in Figure 9 was performed.  Vibrational spectra were 
obtained for six samples of each type of cell membrane.  The best separation between 
the three membrane type was achieved when the principal component 3 (PC3) was 
plotted against principal component (PC2) as illustrated in figure 10.  PC3 was 
associated, after data analysis, to be responsible for changes in lipid saturation in the 
membranes.  Thus, the content of saturated hydrocarbon bonds (vibrational 
frequencies of 1296, 1440, 1460, 2880 cm-1) was determined to be larger for the 
C2C12 myoblasts than for the MRC-5 fibroblasts, and the unsaturated hydrocarbon 
(1660 cm-1) content was determined to be less for the MRC-5 fibroblasts than for the 
C2C12 myoblasts.  The scatter plot shown in Figure 10 indicated that the PC2 and 
PC3 components gave the best separation between the three cell types, confirming the 
conclusion drawn from the Raman spectra shown in Figure 9 that the C2C12 
myoblast membranes contained the largest relative proportion of saturated lipid 
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bonds.  The myotube membranes contained a smaller content of saturated 
hydrocarbon bonds than either the C2C12 or MRC-5 cells.   
 
IV. DISCUSSION  
A total of 39 mixed-cell samples were processed through the DEP chamber at a 
flow rate of 120 µl/hr and an applied voltage of 10V (pk-pk), comprising thirteen 
separations at 409 kHz of C2C12 cells from their differentiated myotubes; C2C12 and 
MRC-5 co-cultured cells separated at 500 kHz; myotube and MRC-5 cell mixtures 
separated at 400 kHz.  The results shown in Figures 5, 7-8 represent the best 
separation purities obtained in these experiments.  Overall, the following mean 
separation purities obtained were: 96.16 ± 3.03% (C2C12 myoblasts, n = 26); 98.9 ± 
0.63% (MRC-5-GFP fibroblasts, n = 26) and 97.0 ± 1.9% for myotubes (n = 26).   
 
A factor contributing to these highly efficient cell separations was the decision, by 
adopting a relatively low rate of fluid flow, to strive for output purity rather than high 
sample throughput.  The flow rate 120 µl/hr corresponded to a mean fluid velocity of 
330 µm/s, so that the average time t taken by a cell to flow through the chamber 
(length 9.4 mm) was 28.5 s.  The mean displacement of the cells by Brownian 
diffusion during this time, in the absence of a DEP force, is tD2  where D is the cell 
diffusion coefficient given by the Stokes-Einstein equation:  
 
 )6/( rkTD ηpi=  (7) 
 
with k the Boltzmann constant, T temperature, η the fluid viscosity and r the 
hydrodynamic radius of the cell.  From equation (7) the diffusion coefficient for a cell 
of radius ~ 5µm at room temperature in an aqueous solution (η = 1 x 10-3 Pa) is ~4 x 
10-14 m2s-1.  After 28.5 seconds the mean displacement ( tD2 ) of a cell by diffusion 
was thus ~1.5 µm.  Contamination arising solely from the Brownian diffusion of non-
target cells into the 50 µm wide ‘funnel’ leading up to the central output fluid port 
would therefore have been extremely low for our experiments.  Also, the 
sedimentation velocity vs of a cell, in the absence of a significant DEP force, is 
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determined by the balance of the Stokes drag force against the gravitational settling 
force:   
 
 
grsvr ρpiηpi ∆= 3)3/4(6  (8) 
 
where ∆ρ is the difference in density between the cell and suspending fluid, and g is 
the gravitational constant.  Based on the density of 1.08 g/cm3 reported for 
lymphocytes38 and the density (1.02 g/cm3) of the DEP medium, vs can be estimated 
as ~3 µm/s1.  Even in the absence of a negative DEP force driving cells downward 
from the upper plane of electrodes, there was thus a high probability that cells passing 
through the chamber would sediment down to the lower electrode plane and thereby 
not escape strong DEP forces.   
 
The frequency dependencies of the Clausius-Mossotti polarizability functions Re(CM) 
for the three cell types can be derived, based on their estimated DEP cross-over (fxo) 
values.  Using the standard form of Re(CM)9,13,15 modelling was performed using 
Matlab (The Maths Works Inc.) and the results are shown in Figure 11.  These curves 
for Re(CM), limited to the region around the range of fxo values for the three cell 
types, assist an understanding of the frequency dependencies and DEP separations 
shown in Figures 5, 7-8.  The large difference of ~300 kHz between the average fxo 
values for the C2C12 myoblasts and myotubes, and that of ~200 kHz for the C2C12 
and their feeder MRC-5-GFP cells, would have been a factor leading to their efficient 
separation by DEP.  The fact that good separations were also obtained for mixtures of 
myotubes and MRC-5-GFP fibroblasts suggests that there was a negligible overlap of 
their fxo distributions about their mean values of around 400 kHz and 500 kHz, 
respectively.  The C2C12 myoblasts and MRC-5-GFP fibroblasts were observed, 
using a microscope (x200), to be of near spherical shape and of roughly equal 
diameter (~10 µm).  As shown in Figure 4(b) these two cell types exhibited closely 
matching flow cytometry forward scatter plots, indicating that their size distributions 
were of a similar lognormal form, skewed to larger cell sizes.  Taking the average 
diameter of the two cell types to be 10 µm, and approximating the lognormal 
distributions shown in Figure 4(b) to be normal ones, the diameters of the C2C12 
myoblasts and MRC-5-GFP fibroblasts can be estimated as 10.6 ± 3.1 µm and 9.4 ± 
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3.3 µm, respectively.  Based on a medium conductivity of 120 mS/m and their 
estimated fxo values of 700 kHz and 500 kHz, respectively, membrane capacitance 
values of 7.3 ± 3.0 mF/m2 and 11.5 ± 5.3 mF/m2 can be estimated for the C2C12 
myoblasts and MRC-5-GFP fibroblasts, respectively.  This suggests that the DEP 
separation of the similar sized C2C12 and MRC-5 cells was mainly associated with 
the difference in their membrane capacitance.  The myotubes were of an elongated 
and convoluted shape, roughly three-times larger in volume than the C2C12 and 
MRC-5-GFP cells.  The derivation of the membrane capacitance using equation (1) is 
only valid for spherical cells9.  Whereas the polarizability of ellipsoids and truncated 
cylinders can be determined39, the ill-defined shape of the myotubes prevents an 
estimation to be made of their membrane capacitance.   
 
The results shown in Figures 9 and 10 indicate that the MRC5 fibroblasts contained a 
lower proportion of saturated hydrocarbon bonds than those of the C2C12 
membranes.  Lipid bilayers formed of saturated ‘rigid’ hydrocarbon chains will be 
thicker than those composed of unsaturated ‘kinked’ chains.  Several explanations of 
the differences found in membrane chemistry are possible, but if the Raman data is 
interpreted as the MRC-5 cells having the thinner membrane, then based on equation 
(2) this would contribute to the finding that the MRC-5 cells possessed the larger 
membrane capacitance.  Also, the relative permittivity of fatty acids decreases with 
increasing saturation.  Examples include linolenic acid (C17H29COOH), linoleic acid 
(C17H31COOH), and oleic acid (C17H33COOH), respectively, with 25oC relative 
permittivies of 2.54, 2.44 and 2.38, respectively40.  This again could contribute to the 
MRC-5-GFP fibroblasts exhibiting a larger membrane capacitance compared to the 
C2C12 myoblasts.  Therefore, membrane capacitance values derived from DEP 
experiments should be considered to reflect both the membrane chemistry (with 
interpretations regarding membrane thickness and dielectric polarizability), as well as 
a measure of the relative value of the membrane-folding factor φm.   
 
V. CONCLUSIONS 
High purities (>96%) of continuous DEP cell separation, with limited loss of cell 
viability, were obtained for myotubes terminally differentiated from C2C12 
myoblasts, and for C2C12 myoblasts co-cultured with MRC-5 fibroblasts.  These cell 
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separations were achieved using a modified form of the DEP chamber and electrode 
arrangement described by Hu et al26.  The major modification was to increase (from 
two to fifteen) the number of quadrupole ‘funnel’ electrode arrays arranged along the 
length of the DEP chamber.  The fact that the distribution of DEP cross-over 
frequencies (fxo) were well separated for the three cell types was essential in leading to 
the high purities of cell separations.  DEP forces acting alone are not capable of 
selectively discriminating to high purity different cells types that have an overlapping 
distribution of fxo values.   
 
Because of the irregular shape of the myotubes, it was not possible to assess the 
relative contributions that membrane capacitance and cell size make regarding the 
different values for fxo exhibited by the C2C12 myoblasts and the myotubes.  
However, because of their similar size and shape the high purity DEP separation of 
co-cultured C2C12 and MRC-5 cells could be attributed to differences in their 
membrane capacitance values.  Furthermore, based on the Raman spectra obtained for 
the membranes of these two cell types it was concluded that, apart from the 
membrane-folding factor φm, membrane thickness and molecular composition may 
also contribute to the specific membrane capacitance of a cell.  Further investigations 
of this will be important in understanding how the DEP characteristics of stem cells 
change with differentiation, for example.  In this work we have used Raman 
spectroscopy because it offers a direct and non-invasive method of obtaining 
structural, packing, and dynamic properties of membrane systems41, 42.  In future work 
we will also exploit the ability of high resolution mass spectroscopy to provide 
quantitative analysis of complex membrane lipid mixtures at the subpicomole level, 
down to sample amounts of 1000 cells43, 44.  
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Day 1 (seeding) 
 
 
Day 2 (after induction) 
 
Day 7 (after induction) 
 
 
 
FIG. 1.  Microscopic images (x20) of the C2C12 myoblasts at the first day of their 
seeding, and two stages (days 2 and 7) after their induction to form myotubes.  The 
myotubes are indicated by arrows. 
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FIG. 2.  Basic details of the DEP chamber and fluidic and electrical connections.  See 
main text for details. 
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Deflected by -ve DEP
 
 
 
 
 
FIG. 3.  Thirty electrodes (each 15 µm wide, spaced 500 µm apart, angled at 18o to 
the fluid flow) were located along both the top and bottom surface of the DEP 
chamber to form a series of fifteen 3D electrode ‘funnels’.  The last set of five 
quadrupole electrodes are shown (left) with a gap of 50 µm between adjacent 
electrode tips.  As shown (right) this facilitated the funnelling of cells deflected by 
negative DEP from the two outer fluid streams into the centre output fluid port.   
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 (a) 
 
 
 
 (b) (c) 
 
FIG. 4.  (a) Flow cytometry control experiments on cell samples (unsorted by DEP) to 
determine appropriate gate settings. (I) Myotubes mixed with MRC-5 GFP 
fibroblasts. (II) C2C12 cells co-cultured with MRC-5 GFP fibroblasts. (b) 
Superimposed forward scatter plots for (blue) C2C12 myoblasts (n = 59,518) and 
(green) MRC-5-GFP fibroblasts (n = 23,343). (c) Flow cytometry result for PI stained 
C2C12 myoblasts after DEP separation from myotubes, indicating 95.2% viability.  
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FIG. 5.  (a) Flow cytometry analyses of a C2C12 sample (7 days after induction to 
myogenic differentiation) collected at 120 µl/hr from the central exit fluid port of the 
DEP chamber as a function of an applied 10 V(pk-pk) voltage frequency.   
(b) Analyses of a sample separation at 409 kHz: (left) collection from central port 
(95.2% negative, 4.79% positive, for Alexa Fluor 488); (right) collection from outer 
flow port (1.42% negative 98.6% positive, for Alexa Fluor 488).    
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FIG. 6.  Western blot analyses: C2C12 myoblasts and myotubes were separated by 
DEP at 409 kHz, and samples collected from the outer and centre fluid exit ports were 
blotted for embryonic myosin.  The bands at ~200kDa (indicative of myotubes) were 
only present in the sample collected from the outer port, in agreement with the results 
shown in Figure 5.  Tubulin was used to calibrate the protein loadings on the gel. 
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FIG. 7.  (a) Flow cytometry analyses of a sample of C2C12 myoblasts co-cultured 
with MRC-5-GFP fibroblasts collected at 120 µl/hr from the central exit fluid port of 
the DEP chamber as a function of an applied 10 V(pk-pk) voltage frequency.   
(b) Analyses of a sample separation at 500 kHz: (left) collection from central port 
(99.9% negative, 0.13% positive, for GFP); (right) collection from outer flow port 
(2.27% negative, 97.7% positive, for GFP).    
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FIG. 8.  (a) Flow cytometry analyses of mixed sample of myotubes and MRC-5-GFP 
fibroblasts collected at 120 µl/hr from the central exit fluid port of the DEP chamber 
as a function of an applied 10 V(pk-pk) voltage frequency.   
(b) Analyses of a sample separation at 400 kHz: (left) collection from central port 
(100% negative, 0.013% positive, for GFP); (right) collection from outer flow port 
(0.92% negative, 99.1% positive, for GFP).    
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FIG. 9.  (a) Normalised Raman spectra of cell membranes for C2C12 myoblasts and 
MRC5-GFP fibroblasts.  Regions 1 and 2 correspond to CH2 and CH3 bending (1440, 
1460 cm-1)32, 33 and CH2 stretching vibrations34, 35 for saturated long CH chains (2860, 
2840 and 2880 cm-1), respectively.  (b) Expanded region 1.  (c) Expanded region 2.  
This data shows that the membranes of MRC5 fibroblasts have a lower proportion of 
saturated hydrocarbon bonds compared to C2C12 myoblasts. 
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FIG 10.  Scatter plot for the principal component analysis between PC3 and PC2.  The 
PC3 loading gave the best separation of data between the three membrane types, and 
these are delineated by the two solid straight lines.  
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FIG. 11.  MATLAB modelling of the Clausius-Mossotti polarizability factor for the 
three cell types, based on their estimated DEP crossover frequency values. 
 
 
 
 
 
 
 
 
